Aroa achieves key milestone with seven million ... of supportive clinical evidence It’s been a big journey forAroa Biosurgery (ASX:ARX), which was founded in 2008 under the name Mesynthes ...
Hosted on MSN1mon
Aroa Biosurgery Announces Webinar for Quarterly Results and Clinical Study InsightsAroa Biosurgery Ltd ( (AU:ARX)) has issued an announcement. Aroa Biosurgery Limited is set to conduct a webinar featuring CEO Brian Ward and CFO James Agnew on January 29th to discuss the company ...
In a report released today, Shane Storey from Wilsons maintained a Buy rating on Aroa Biosurgery Ltd (ARX – Research Report), with a price target of A$0.75. The company’s shares closed today ...
Followed categories will be added to My News. In this episode Tim chats with Brian Ward, founder and CEO at Aroa Biosurgery (ASX:ARX). Aroa was founded in 2008 by Veterinarian Surgeon Dr Ward and ...
It’s been a big journey for Aroa Biosurgery (ASX:ARX), which was founded in 2008 under the name Mesynthes, by CEO Dr Brian ...
This article was developed in collaboration with Aroa Biosurgery, a Stockhead advertiser at the time of publishing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback